BioTech 365

SEPTEMBER 16, 2021

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: ESMO: Novartis links prostate cancer drug to improved pain, quality of life as regulatory filings near.ESMO: Novartis links prostate cancer drug to improved pain, quality of life … Continue reading →

Drugs 40

Drugs Research 40

BioTech 365

OCTOBER 27, 2021

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Duke and UC scientists find a potential remedy for chronic pain from a ‘junkyard of cancer drugs’ Duke and UC scientists find a potential remedy for chronic pain … Continue reading →

Scientist 40

Scientist Drugs Research 40

BioTech 365

MARCH 18, 2021

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: How a map of cell signaling networks could identify new targets for pain drugs.How a map of cell signaling networks could identify new targets for pain drugs … Continue reading →

Drugs 40

Drugs Research 40

BioTech 365

MAY 13, 2021

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: NEA-backed Allay exits stealth with clinical pain data, plans to reduce need for opioids.NEA-backed Allay exits stealth with clinical pain data, plans to reduce need for opioids … Continue reading →

Research 40

Research 40

NPR Health - Shots

NOVEMBER 3, 2022

The updated recommendations seek to course correct after guidelines from 2016 were criticized for harshly limiting access to needed pain medication. Osorio/Tribune News Service via Getty Images) Image credit: Jose M.

Doctors 145

Doctors Doctor 145

Pharma Times

AUGUST 2, 2023

The deal covers 13 brands across six therapeutic areas, mainly focused on pain treatment - News - PharmaTimes

Branding 102

Branding 102

Pharma Times

AUGUST 1, 2023

The approval involves the roll-out of a non-cancer chronic pain study for up to 5,000 patients - News - PharmaTimes

Medicine 104

Medicine Trials 104

Pharma Times

JULY 31, 2023

Novel therapy, OK-101, offers a potential way of relieving neuropathic corneal pain - News - PharmaTimes

Clinical Trials 94

Clinical Trials Clinical Trials Trials 94

Medical Xpress

MARCH 7, 2023

New research offers up some good news for diehard marathon runners: You don't necessarily have to give up running if you are experiencing hip or knee pain.

Research 74

Research 74

STAT News

MARCH 17, 2023

It was an abrupt end to what Nicholson depicted just months earlier as a booming business with plans for new clinics and treatments. To patients, the news came as a complete shock. Read the rest…

124

124

pharmaphorum

NOVEMBER 3, 2022

The hope that nerve growth factor (NGF) inhibitors could be an alternative to opioid for pain relief has finally been extinguished with the news that Regeneron had abandoned the last drug in the class. Faced with the regulatory resistance, Pfizer gave up on tanezumab shortly afterwards.

Drugs 52

Drugs Antibody Allergies Development 52

World of DTC Marketing

APRIL 14, 2022

Sometimes they are censored, but too often, they aren’t, which causes needless pain. Misinformation and trolls abound on every platform, often repeating FOX news lies. According to STAT News, “Americans consume an unhealthy diet of health misinformation. I couldn’t believe what I was reading.

Branding 218

Branding Pharma Companies Containment Vaccination 218

STAT News

OCTOBER 14, 2022

Hired someone new and exciting? Share the news with us, and we’ll share it with others.  Previously, he worked at Centrexion Therapeutics, where he was executive director of clinical development, and before, that he was clinical lead for pain therapeutics at Regeneron Pharmaceuticals. Promoted a rising star?

Clinical Development 98

Clinical Development Development 98

The Pharma Data

NOVEMBER 4, 2020

Adults Had Chronic Pain in 2019. adults reported chronic pain in the last three months, according to a November data brief published by the U.S. from the National Center for Health Statistics in Hyattsville, Maryland, and colleagues examined chronic pain and high-impact chronic pain in the previous three months among U.S.

Research 52

Research 52

Pharmaceutical Technology

JULY 26, 2022

Also in this issue, a feature takes a look at how clinical trials measure pain, the challenges of developing drugs for neglected tropical diseases , and whether Russia’s domestic pharma capabilities may shield the country from the negative effects of the sanctions imposed on it following the war in Ukraine.

Genome Project 130

Genome Project Genome Genomics Clinical Trials 130

STAT News

SEPTEMBER 1, 2022

Hope these engaging news items help ease the pain. The Food and Drug Administration authorized new Covid booster shots that more closely match the strains of the coronavirus currently circulating in the U.S., Oh, the agony. STAT tells us.

Regulation 98

Regulation Vaccination Vaccine Drugs 98

The Pharma Data

NOVEMBER 10, 2020

Spinal Cord Stimulation May Ease Diabetic Nerve Pain. from the University of Arkansas for Medical Sciences in Fayetteville, and colleagues randomly assigned (1:1) 216 patients with painful DN for ?12 50 percent pain relief and without worsening baseline neurological deficit. More News Resources. Professional.

Medicine 52

Medicine Research 52

ECRG Media's Clinical Research Podcast

SEPTEMBER 3, 2019

Top 5 Pain Points of Clinical Research In this episode i break down from my point of view the top 5 pain points of clinical research. Don't forget to Subscribe for new content! Don't forget to Subscribe for new content!

Clinical Research 52

Clinical Research Research Production 52

ECRG Media's Clinical Research Podcast

SEPTEMBER 3, 2019

Top 5 Pain Points of Clinical Research. In this episode i break down from my point of view the top 5 pain points of clinical research. Don't forget to Subscribe for new content! Watch: » Industry News: [link]. » Watch: » Industry News: [link]. » News and Product Reviews. Watch: » Industry News: [link]. »

Clinical Research 52

Clinical Research Research Production 52

Camargo

JUNE 4, 2021

Each month, Camargo’s “In the News” series highlights important changes and advancements in the regulatory and development space and explores how those changes could impact your program. Approval of the Month: Non-Opioid for Post-Surgical Pain Gets FDA Nod. In the News: May 2021 Regulatory and Development Updates.

Development 130

Development Production Drugs Marketing 130

XTalks

NOVEMBER 30, 2023

Pfizer spinout SpringWorks Therapeutics’ Ogsiveo (nirogacestat) has received US Food and Drug Administration (FDA) approval for the treatment of desmoid tumors, an ultra-rare subtype of non-cancerous soft tissue sarcomas that can cause severe pain and disfigurement. While desmoid tumors do not metastasize, they are difficult to treat.

FDA Approval 101

FDA Approval Trials Clinical Trials Clinical Trials 101

World of DTC Marketing

JULY 6, 2022

Endpoint News reported “Three major drug distributors are off the hook for what may have been a $2.5 Good faith when pain management “stores” were all over the area prescribing the drug for a few dollars? If this news doesn’t raise your blood pressure than you don’t belong in this industry.

Pharmacy 238

Pharmacy Doctors Doctor Sales 238

pharmaphorum

OCTOBER 12, 2021

Meanwhile, in other biotech M&A news this week, Pacira expanded its push into non-opioid therapies for pain with a deal to acquire Flexion Therapeutics valued a $450 million, or $630 million including the assumption of debt. The post Supernus bulks up its Parkinson’s portfolio with Adamas takeover appeared first on.

Sales 77

Sales Gene Therapy Production Marketing 77

The Pharma Data

OCTOBER 23, 2020

There’s an overall myth among athletes that admitting pain is a sign of weakness and failure, the researchers said. Irish and Australian rowers in this study felt compromised by lower back pain, which is common in the sport, the study authors said. Also, many felt they had to keep competing and training even when in pain.

Medicine 52

Medicine Research 52

The Pharma Data

DECEMBER 1, 2020

1, 2020 — Virtual reality glasses or hypnosis can relieve pain and anxiety in people having short medical procedures, a new study finds. Patients were randomly assigned to standard pain medications, VR glasses or hypnosis before and during the procedure. TUESDAY, Dec. The study is by Dr. E.

Research 52

Research 52

The Pharma Data

OCTOBER 15, 2020

veterans with unhealthy alcohol use, reducing drinking may improve or resolve various conditions including pain interference symptoms and substance use, although most correlations are not significant, according to a study published online Oct. for pain interference symptoms, 1.57 More News Resources. THURSDAY, Oct.

Medicine 52

Medicine Research 52

The Pharma Data

OCTOBER 17, 2020

Consumer News. Lowering your blood pressure is one of the most important things you can do to reduce your risk of having a heart attack or stroke,” Dr. Mitchell Elkind, president of the American Heart Association (AHA), said in an AHA news release. More News Resources. How to Keep High Blood Pressure at Bay. SATURDAY, Oct.

Doctors 52

Doctors Doctor Production Drugs 52

The Pharma Data

JANUARY 20, 2021

Pollen May Trigger Urologic Chronic Pelvic Pain Flares. 20, 2021 — Pollen count increases past medium or higher thresholds are associated with increased flare onset among some individuals with urologic chronic pelvic pain syndrome (UCPPS), according to a study published online Dec. More News Resources. Professional.

Allergies 52

Allergies Medicine Research 52

The Pharma Data

OCTOBER 16, 2020

16, 2020 — Most older adults using cannabis report initiating use after the age of 60 years primarily to treat pain, according to a study published online Oct. Other participants reported using cannabis for targeting pain/arthritis (73 percent), sleep disturbance (29 percent), anxiety (24 percent), and depression (17 percent).

Research 52

Research 52

XTalks

JULY 22, 2021

News agencies like Reuters were at the helm of the misleading headlines, which took the comments out of context, stating that mixing and matching vaccines was outright dangerous. Users simply lick the strip and insert it into a glucose monitor. Read the full articles here: Researchers Develop World’s First Saliva Test for Diabetes.

Life Science 98

Life Science Vaccination Vaccine Scientist 98

The Pharma Data

JANUARY 9, 2021

If the answer is yes, the individual should be referred to a board-certified allergist for evaluation before getting the COVID-19 vaccination, ACAAI said in a news release. The academy also said COVID-19 vaccines should be given in a health care facility where an allergic reaction can be treated. These usually resolve in a few days.

Vaccination 52

Vaccination Vaccine Allergies Immune Response 52

pharmaphorum

DECEMBER 7, 2022

That, in turn, is resulting in mistakes in experimental procedures that mean they have to be repeated, increasing the unnecessary loss of animal life, says the news wire. Reuters said it has interviewed 20 current and former Neuralink employees in its investigation, as well as reviewing internal company documents.

Clinical Trials 119

Clinical Trials Clinical Trials Research Development 119

The Pharma Data

AUGUST 13, 2020

But like many who have had the virus, the father of two was still in pain and coughing weeks after being discharged. Mr Madhani, who was also found to have pneumonia, said he was “in constant pain” in hospital. He said: “After coming home, the first month of recovery was still painful.

Research 52

Research Development 52

Drug Discovery World

JULY 15, 2022

News round-up by DDW’s Reece Armstrong for 11 – 15 July. The first new treatment in 20 years that prevents a common, painful side-effect in patients with sickle cell disorder (SCD) has been issued interim acceptance by the Scottish Medicines Consortium (SMC). Urgency a must for global fight against AMR, report says.

Life Science 52

Life Science Drugs Vaccination Vaccine 52

Pharmaceutical Technology

OCTOBER 13, 2022

The news of the offer came just weeks after Myovant and its partner, Pfizer , received the US Food and Drug Administration's (FDA) expanded approval of Myfembree (estradiol + norethindrone acetate + relugolix) for the management of moderate to severe pain associated with endometriosis.

Hormones 130

Hormones FDA Approval Drugs Marketing 130

Drug Discovery World

MARCH 31, 2023

SOM is not only a debilitatingly painful side effect of chemotherapy and radiation, but it is also potentially life-threatening because of concomitant infections. In this case, the unmet medical need is severe oral mucositis (SOM), for which no treatment is currently available.

Drugs 52

Drugs Clinical Trials Clinical Trials Trials 52

The Pharma Data

OCTOBER 26, 2020

They cannot turn their toes as easily, flex their hips or lift their legs high enough to avoid obstacles due to physical limitations as well as pain, resulting in falls and fragility fractures.” “Those who had TJA fell far less than those who did not,” Schwarzkopf said in a journal news release.

Drugs 52

Drugs Research 52